Labroots
Published September 26, 2026 · Updated September 27, 2026
Janssen Pharmaceuticals Wins Patent Infringement Case for Depression Treatment Spravato
Read the full story at Labroots
Johnson & Johnson subsidiary Janssen Pharmaceuticals won a patent infringement case for Spravato against biotech competitor Sandoz last month.
Surfaced by this Google Alert
- Psychedelic biotech
